Market cap
$1 Mln
Market cap
$1 Mln
Revenue (TTM)
$37 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.4 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-4.9
Debt to Equity
1.8
Book Value
$--
EPS
$-1
Face value
--
Shares outstanding
3,019,890
CFO
$-187.21 Mln
EBITDA
$-247.62 Mln
Net Profit
$-429.82 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Danimer Scientific (DNMR)
| -83.3 | -- | -- | -92.6 | -82.8 | -79.5 | -- |
|
BSE Sensex*
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
Danimer Scientific (DNMR)
| -94.7 | -43.0 | -79.0 | -63.8 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Danimer Scientific, Inc., a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a... biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company products are used in various applications, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia. On March 18, 2025, Danimer Scientific, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Read more
Interim Executive Chairman
Mr. Richard J. Hendrix
CEO & Chairman of the Board
Mr. Stephen E. Croskrey
Headquarters
Bainbridge, GA
Website
The share price of Danimer Scientific Inc (DNMR) is $0.35 (NYSE) as of 30-Dec-2025 16:00 EDT. Danimer Scientific Inc (DNMR) has given a return of -82.77% in the last 3 years.
Since, TTM earnings of Danimer Scientific Inc (DNMR) is negative, P/E ratio is not available.
The P/B ratio of Danimer Scientific Inc (DNMR) is 0.01 times as on 30-Dec-2025, a 100 discount to its peers’ median range of 3.11 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
-0.67
|
0.37
|
|
2022
|
-1.01
|
0.48
|
|
2021
|
-14.23
|
1.71
|
|
2020
|
-41.80
|
1.43
|
|
2019
|
--
|
--
|
The 52-week high and low of Danimer Scientific Inc (DNMR) are Rs 4.74 and Rs 0.33 as of 25-Apr-2026.
Danimer Scientific Inc (DNMR) has a market capitalisation of $ 1 Mln as on 30-Dec-2025. As per SEBI classification, it is a Small Cap company.
Before investing in Danimer Scientific Inc (DNMR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.